Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Male infertility; and common findings: Bronchiectasis. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Bronchiectasis, Recurrent respiratory infections |
Hormones |
TTC12 function has not been fully characterized.
Ciliary dyskinesia, primary, 45 is caused by mutations in the TTC12 gene on chromosome 11.
Genetic testing for TTC12 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ciliary dyskinesia, primary, 45 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
No clinical trials have been registered for ciliary dyskinesia, primary, 45.
16 publications have been identified in PubMed for ciliary dyskinesia, primary, 45. Research spans Diagnostic / Biomarker (31%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 5 | 31% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about ciliary dyskinesia, primary, 45
1 |
Male infertility |
Blood and immune system | 1 | Recurrent respiratory infections |
Laboratory research
4 |
25% |
Disease patterns and progression | 3 | 19% |
Research summaries | 2 | 13% |
Other research | 1 | 6% |
Clinical study results | 1 | 6% |
Ergen YM (2026). [PMID: 41816728](https://pubmed.ncbi.nlm.nih.gov/41816728/). *Turk J Med Sci*. [Epidemiology / Natural History]
Li K (2026). [PMID: 41168986](https://pubmed.ncbi.nlm.nih.gov/41168986/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Oud MS (2025). [PMID: 39180390](https://pubmed.ncbi.nlm.nih.gov/39180390/). *Andrology*. [Diagnostic / Biomarker]
Lam YT (2025). [PMID: 41397810](https://pubmed.ncbi.nlm.nih.gov/41397810/). *BMJ Open Respir Res*. [Epidemiology / Natural History]
Burns G (2025). [PMID: 41088162](https://pubmed.ncbi.nlm.nih.gov/41088162/). *Orphanet J Rare Dis*. [Diagnostic / Biomarker]
Zhang MT (2025). [PMID: 40159055](https://pubmed.ncbi.nlm.nih.gov/40159055/). *Zhonghua Jie He He Hu Xi Za Zhi*. [Basic Science / Preclinical]
Gaupmann R (2025). [PMID: 41248115](https://pubmed.ncbi.nlm.nih.gov/41248115/). *Horm Res Paediatr*. [Epidemiology / Natural History]
Farzal Z (2025). [PMID: 39896853](https://pubmed.ncbi.nlm.nih.gov/39896853/). *OTO Open*. [Clinical Trial Publication]
Burns G (2025). [PMID: 40321264](https://pubmed.ncbi.nlm.nih.gov/40321264/). *medRxiv*. [Diagnostic / Biomarker]
Román-Ríos G (2025). [PMID: 41149140](https://pubmed.ncbi.nlm.nih.gov/41149140/). *Adv Respir Med*. [Other]